用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2016-05-10 AccNo: 0001144204-16-100426 Size: 26 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K/A [Amend] - Current report Filed: 2016-05-10 AccNo: 0001144204-16-100251 Size: 44 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Off...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-09 AccNo: 0001144204-16-099917 Size: 25 KBItem 4.01: Changes in Registrant's Certifying AccountantItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-05-04 AccNo: 0001299265-16-000006 Size: 118 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-03 AccNo: 0001144204-16-098686 Size: 56 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementItem 5.02: Departur...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-04-26 AccNo: 0001144204-16-096394 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-04-13 AccNo: 0001144204-16-094157 Size: 53 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementItem 9.01: Financia...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-04-12 AccNo: 0001354488-16-006947 Size: 199 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-04-06 AccNo: 0001144204-16-093022 Size: 23 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem ...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-03-29 AccNo: 0001144204-16-090941 Size: 226 KBItem 2.02: Results of Operations and Financial ConditionItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Off...